Format

Send to

Choose Destination
Nat Rev Drug Discov. 2012 Mar 1;11(3):171-2. doi: 10.1038/nrd3694.

Advancing the development of tuberculosis therapy.

Author information

1
Division of Infection and Immunity, University College London, London NW3 2PF, UK. a.zumla@ucl.ac.uk

Abstract

Although the development of novel drugs and combination regimens for tuberculosis has accelerated in recent years, the pipeline remains thin and major challenges remain to be addressed in efficiently evaluating newer drugs to improve treatment outcomes, shorten duration of therapy and tackle drug resistance.

PMID:
22378254
DOI:
10.1038/nrd3694
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center